Recommended treatment for men with metastatic prostate cancer could be turned on its ear by a clinical trial spanning five countries and led by Dr. Isaac Kim, professor and department chair of the ...

ASTRO released a clinical practice guideline with evidence-based recommendations for palliative radiation therapy for ...

Metastasis is the spread of cancer to a part of the body distant from the original primary cancer. This occurs through the transfer of malignant or cancerous cells via lymph or blood. The new ...

Radium-223, enzalutamide, and a bone-protecting agent may be a new treatment option for mCRPC patients with bone metastases, according to Silke Gillessen, MD.

Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients with solid tumors and bone lesions associated with multiple myeloma.

Oncobone Ventures Ltd. and Origenis GmbH have signed a framework agreement to develop novel therapies targeting cancer bone metastasis. Origenis leverages its artificial intelligence (AI)-driven ...

Intravenous; mCRPC: Metastatic castration-resistant prostate cancer; P: Placebo ... the incidence of skeletal-related events (SREs) in bone metastatic CRPC (mCRPC). Denosumab compared with ...

A retrospective study revealed differences in metastasis patterns and treatment utilization by ethnicity among patients with breast cancer and brain metastasis.

"Metastatic breast cancer is where breast cancer moves from the origin in the breast through the blood, and through the lymph ...

Elacestrant, a selective estrogen receptor degrader, demonstrated significant improvements in progression-free survival (PFS) ...